Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi

Journal of Infectious Diseases

Volumn 210, Issue 7, 2014, Pages 1110-1114

  Frosch, Anne E P ^a,b   Laufer, Miriam K ^a   Mathanga, Don P ^d   Takala Harrison, Shannon ^a   Skarbinski, Jacek ^c,f   Claassen, Cassidy W ^a   Dzinjalamala, Fraction K ^e   Plowe, Christopher V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Malaria Alert Center   (United States)

^e UNIVERSITY OF MALAWI   (Malawi)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Africa; Chloroquine; Malaria; Malawi; PfCRT; Plasmodium falciparum; Resistance

Indexed keywords

CHLOROQUINE; PROTOZOAL DNA; ANTIMALARIAL AGENT; CARRIER PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN;

ANEMIA; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; ASEXUAL PARASITEMIA; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALAWI; NONHUMAN; PARASITEMIA; PFCRT GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PYROSEQUENCING; DNA SEQUENCE; DRUG EFFECTS; DRUG SENSITIVITY; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MALE; PARASITOLOGY;

ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; CROSS-SECTIONAL STUDIES; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALAWI; MALE; MEMBRANE TRANSPORT PROTEINS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84906936219     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu216     Document Type: Article

References (15)

1. Kublin JG, Cortese JF, Njunju EM, et al. Reemergence of chloroquinesensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 2003;187:1870-5.
2. Laufer MK, Thesing PC, Eddington ND, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 2006;355:1959-66.
3. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquineresistant falciparum malaria. N Engl J Med 2001;344:257-63.
4. Laufer MK, Thesing PC, Dzinjalamala FK, et al. A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria. PLoS One 2012;7:e42284.
5. Enosse S, Magnussen P, Abacassamo F, et al. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique. Malar J 2008;7:115.
6. Raman J, Mauff K, Muianga P, Mussa A, Maharaj R, Barnes KI. Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. PLoS One 2011;6:e25992.
7. Frosch AE, Venkatesan M, Laufer MK. Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data. Malar J 2011;10:116.
8. Dzinjalamala FK, Laufer MK, Connors N, et al. Surveillance to confirm the disappearance of chloroquine resistant malaria following chloroquine withdrawal in Malawi. Malawi Med J 2009;21:34-49.
9. Mita T, Kaneko A, Lum JK, et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 2003;68:413-5.
10. Juliano JJ, Kwiek JJ, Cappell K, Mwapasa V, Meshnick SR. Minorityvariant pfcrt K76T mutations and chloroquine resistance, Malawi. Emerg Infect Dis 2007;13:872-7.
11. Bridges DJ, Molyneux M, Nkhoma S. Low level genotypic chloroquine resistance near Malawi's northern border with Tanzania. Trop Med Int Health 2009;14:1093-6.
12. Skarbinski J, Mwandama D, Luka M, et al. Impact of health facilitybased insecticide treated bednet distribution in Malawi: progress and challenges towards achieving universal coverage. PLoS One 2011;6:e21995.
13. Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J Infect Dis 2010;202:801-8.
14. Ecker A, Lehane AM, Clain J, Fidock DA. PfCRT and its role in antimalarial drug resistance. Trends Parasitol 2012;28:504-14.
15. Thomsen TT, Madsen LB, Hansson HH, et al. Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, Southern Mozambique. Am J Trop Med Hyg 2013;88:536-41.